NCT05403281 - A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 5, 2021

Primary Completion Date

December 3, 2021

Study Completion Date

March 28, 2022

Conditions

Healthy Subjects

Interventions

DRUG

DW6012

"Drug: DW6012 Single oral administration of DW6012 after an overnight fast~Drug: Dapagliflozin and Sitagliptin Single oral administration of Dapagliflozin and Sitagliptin after an overnight fast"

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si